Rockwell Medical (NASDAQ:RMTI) announced the launch of a convenience pack including pre-mixed containers of the company’s hemodialysis concentrate products, offering in-home dialysis patients and acute dialysis facilities easier handling and streamlined workflow.
The two one-gallon pre-mixed containers of Rockwell’s hemodialysis concentrate products—CitraPure, RenalPure, or SteriLyte—will increase accessibility and convenience for vulnerable patients with end-stage kidney disease and their healthcare providers.
Hemodialysis, the most common treatment for end-stage kidney disease, is typically performed at outpatient dialysis centers, hospital-based centers, skilled nursing facilities, or in patients’ homes.
In a statement, Tim Chole, CMO of Rockwell, said, “There is a patient-centric movement to drive dialysis treatments into the home to reduce the cost and complexity of dialysis treatments, all the while transforming the dialysis experience for patients. Rockwell is excited to become a critical player in the at-home market to support hemodialysis patients and their journey to take control over their time and treatments.”
